Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 552

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 5
Chunk 552
---
7,887    ​    14.8    ​    10,071   ​    22.9 
Total                 ​   48,617   ​    100.0   ​    53,392   ​    100.0   ​    43,933   ​    100.0
​
Our selling expenses primarily comprise selling expenses incurred by our Oncology/Immunology operations by HUTCHMED Limited for sales and marketing expenses and related personnel expenses for our unpartnered drug Sulanda. It also includes sales and marketing expenses and related personnel expenses incurred by our Other Ventures in their distribution and marketing of pharmaceutical and healthcare products.
​

Administrative Expenses
The following table sets forth the components of our administrative expenses for the years indicated.
Administrative expenses are also incurred by our corporate head office, which are not allocated to either Oncology/Immunology or Other Ventures.

           ​              ​     ​      ​      ​     ​      ​      ​      ​     ​      ​      ​      ​  
-------------------------------------------------------------------------------------------------------
​                         ​                                                     Year Ended December 31,
​                         ​                  2024   ​                   2023   ​                   2022
​                              $’000            %         $’000            %         $’000            %
Administrative Expenses   ​        ​   ​        ​   ​         ​   ​        ​   ​         ​   ​        ​
Oncology/Immunology       ​   36,910   ​     57.4   ​    47,966   ​     60.1   ​    58,395   ​     63.3
Other Ventures            ​    4,996   ​      7.8   ​     5,435   ​      6.8   ​     3,482   ​      3.8
Corporate Head Office     ​   22,390   ​     34.8   ​    26,383   ​     33.1   ​    30,296   ​     32.9
Total                     ​   64,296   ​    100.0   ​    79,784   ​    100.0   ​    92,173   ​    100.0
​
Oncology/Immunology’s administrative expenses are primarily comprised of the salaries and benefits of administrative staff, office leases and other overhead expenses incurred by